- Home
- KRMD vs STXS Comparison
KRMD vs STXS Comparison
Compare KRMD & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- STXS
- Stock Information
- Founded
- KRMD 1980
- STXS 1990
- Country
- KRMD United States
- STXS United States
- Employees
- KRMD N/A
- STXS N/A
- Industry
- KRMD Medical/Dental Instruments
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KRMD Health Care
- STXS Health Care
- Exchange
- KRMD Nasdaq
- STXS Nasdaq
- Market Cap
- KRMD 182.0M
- STXS 189.8M
- IPO Year
- KRMD N/A
- STXS 2004
- Fundamental
- Price
- KRMD $3.96
- STXS $2.12
- Analyst Decision
- KRMD Strong Buy
- STXS Strong Buy
- Analyst Count
- KRMD 4
- STXS 2
- Target Price
- KRMD $4.13
- STXS $4.50
- AVG Volume (30 Days)
- KRMD 99.7K
- STXS 422.5K
- Earning Date
- KRMD 11-13-2024
- STXS 03-03-2025
- Dividend Yield
- KRMD N/A
- STXS N/A
- EPS Growth
- KRMD N/A
- STXS N/A
- EPS
- KRMD N/A
- STXS N/A
- Revenue
- KRMD $31,993,796.00
- STXS $25,143,000.00
- Revenue This Year
- KRMD $17.79
- STXS $1.16
- Revenue Next Year
- KRMD $15.73
- STXS $55.65
- P/E Ratio
- KRMD N/A
- STXS N/A
- Revenue Growth
- KRMD 11.57
- STXS N/A
- 52 Week Low
- KRMD $1.98
- STXS $1.66
- 52 Week High
- KRMD $4.60
- STXS $3.29
- Technical
- Relative Strength Index (RSI)
- KRMD 52.61
- STXS 43.74
- Support Level
- KRMD $3.79
- STXS $2.21
- Resistance Level
- KRMD $4.05
- STXS $2.72
- Average True Range (ATR)
- KRMD 0.18
- STXS 0.16
- MACD
- KRMD -0.03
- STXS -0.02
- Stochastic Oscillator
- KRMD 63.92
- STXS 10.37
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.